查看購物車
  • English
封面
市場調查報告書
商品編碼
1912771

醫用多用途引流導管市場：按產品類型、材質、尺寸、應用、最終用戶和銷售管道分類 - 全球預測（2026-2032年）

Medical Multi-Use Drainage Catheters Market by Product Type, Material, Size, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫用多用途引流導管市場價值將達到 7.7527 億美元，到 2026 年將成長至 8.3689 億美元，到 2032 年將達到 14.2027 億美元，複合年成長率為 9.03%。

關鍵市場統計數據
基準年 2025 7.7527億美元
預計年份：2026年 8.3689億美元
預測年份 2032 1,420,270,000 美元
複合年成長率 (%) 9.03%

為了闡明影響多用途引流導管的設計、應用和性能預期的重要臨床和技術要務。

多用途引流導管在現代介入醫學中發揮核心作用，涵蓋多個臨床專科，可在各種臨床環境下實現持續引流、標靶治療和診斷性取樣。材料科學、器械設計和手術技術的進步不斷拓展這些器械的臨床效用，同時也提高了人們對其安全性、耐用性和病患舒適度的期望。同時，強調門診手術和日間管理的醫療模式的轉變，也拓展了引流導管的應用範圍，並影響臨床醫師的選擇和採購重點。

識別能夠重新定義引流導管解決方案產品開發和採購路徑的臨床、材料和商業性變更。

可重複使用引流導管的市場格局正受到多項變革性變化的影響，這些變化共同作用，影響著臨床實踐、採購行為和產品開發重點。首先，聚氨酯、矽膠和特氟龍等材料的創新提高了生物相容性並減少了污染，促使臨床醫生根據長期性能特徵重新評估器械的選擇。同時，管腔結構的進步，包括單腔、雙腔和三腔結構，正在擴展器械的功能，以便在一次手術中滿足複雜的引流和治療需求。

評估2025年美國關稅變化對引流導管製造商的設備採購、供應商策略和供應鏈韌性的實際影響

美國2025年關稅政策的最新進展為醫療設備供應鏈的籌資策略、供應商選擇和成本管理帶來了新的考量。關稅調整正在改變不同製造地的經濟效益，促使企業重新評估離岸生產和本地生產之間的平衡。因此，採購團隊和供應鏈經理更加重視供應商多元化，並尋找替代供應商以降低關稅相關成本波動所帶來的風險。

以細分市場主導的策略要務：將設備配置、臨床應用、終端用戶趨勢、材料、尺寸和通路選擇與商業成功聯繫起來

從細分市場觀點，我們可以發現產品類型、臨床應用、終端用戶環境、材料、器材尺寸和銷售管道等方面存在著不同的機會和營運重點。這些因素會影響商業和研發策略。就產品類型而言，我們區分雙腔、單腔和三腔三種配置，每種配置在功能、插入複雜性和維護要求方面各有優劣。心臟病學、胃腸病學、腎臟病學和泌尿系統等領域的廣泛應用，對產品的性能、滅菌方法和臨床醫生培訓提出了獨特的要求。這些因素都應體現在有針對性的臨床證據產生和標籤策略的發展中。

重點闡述了區域監管、臨床和採購特徵如何影響美洲、歐洲、中東和非洲以及亞太地區的產品策略。

區域趨勢對監管要求、報銷實際情況和臨床實踐規範有顯著影響，導致產品開發和商業性化執行的優先事項有所不同。在美洲，尤其注重遵守集中式監管流程，以及醫療設備聲明與支付方標準保持一致，這種環境通常鼓勵產生嚴謹的臨床證據並參與結構化的醫院採購活動。同時，在歐洲、中東和非洲地區，不同的管理體制和採購行為往往需要根據當地情況制定監管策略、適應性標籤和靈活的分銷方式，以滿足各國的特定要求和臨床實踐。

差異化洞察闡述了專注於創新、卓越製造、臨床夥伴關係和商業模式如何決定競爭優勢。

多用途引流導管領域的企業發展趨勢反映了創新領導、製造能力和商業性覆蓋範圍之間的平衡。主要企業透過投資尖端材料和塗層技術、運用監管專業知識確保廣泛的標籤覆蓋，以及與醫療系統合作獲取真實世界證據，脫穎而出。與學術機構和專家進行策略合作，透過展示手術效率和以患者為中心的療效，提升產品信譽度並加速臨床應用。

實際可行、優先排序的策略行動，協調產品設計、供應鏈韌性、臨床證據和商業管道，以加速產品推廣應用並降低風險。

透過一系列優先且切實可行的步驟，產業領導者可以加速產品推廣並保持成長，同時克服當前臨床、監管和商業性的挑戰。首先，將產品開發與臨床醫生的工作流程需求和材料性能目標相結合，可以確保設計變更能夠帶來可衡量的可用性和患者療效提升。這需要在開發過程中持續收集臨床醫生的意見，並進行有針對性的上市後研究，以檢驗產品在實際應用中的表現。

對多資訊來源調查方法、證據三角驗證和檢驗程序進行透明描述，以得出對相關人員可操作的見解。

本研究結合了對臨床醫生、採購負責人和行業高管的訪談，並輔以對監管指南、臨床文獻和供應鏈數據的二次分析，以確保研究結果的可靠三角驗證。主要研究包括與心臟病學、胃腸病學、腎臟病學和泌尿系統的介入醫師，以及來自醫院、門診手術中心、診所和專科醫療中心的採購和供應鏈負責人進行結構化諮詢。這些訪談揭示了醫療設備在實際應用中的性能優先事項、採購理由和服務期望。

綜合分析將器械創新、不斷發展的臨床實踐、供應鏈韌性和商業化聯繫起來的策略意義，以推動相關人員採取決定性行動。

總而言之，材料技術的進步、診療流程向門診轉移以及不斷變化的供應鏈壓力，正在共同重塑引流導管領域製造商和相關人員的優先事項。器械設計人員必須平衡導管的柔軟性、抗污染性和管腔設計，以滿足不同的臨床需求；而營運經理則必須預測受關稅波動和區域監管複雜性影響的採購趨勢。因此，商業性成功取決於能否將臨床證據、供應彈性和針對醫院、門診中心、診所和專科診所特定需求量身定做的分銷策略相結合。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 醫用多用途引流導管市場（依產品類型分類）

  • 雙腔
  • 單腔
  • 三流明

9. 醫用多用途引流導管市場（依材料分類）

  • 聚氨酯
  • 矽酮
  • 鐵氟龍

第10章 醫用多用途引流導管市場（依尺寸分類）

  • 11-14 Fr
  • 5-7 Fr
  • 8-10 Fr
  • 14 法郎或以上

第11章 醫用多用途引流導管市場（依應用領域分類）

  • 心臟病學
  • 胃腸病學
  • 腎臟病學
  • 泌尿系統

第12章 依最終用戶分類的醫用多用途引流導管市場

  • 門診手術中心
  • 診所
  • 醫院
  • 專業中心

第13章 醫用多用途引流導管市場（依銷售管道分類）

  • 直銷
  • 批發的
  • 線上銷售

第14章 各地區醫用多用途引流導管市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 醫用多用途引流導管市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國醫用多用途引流導管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國醫用多用途引流導管市場

第18章：中國醫用多用途引流導管市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Convatec Group Plc
  • Cook Medical LLC
  • Johnson & Johnson
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-AE420CB13A89

The Medical Multi-Use Drainage Catheters Market was valued at USD 775.27 million in 2025 and is projected to grow to USD 836.89 million in 2026, with a CAGR of 9.03%, reaching USD 1,420.27 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 775.27 million
Estimated Year [2026] USD 836.89 million
Forecast Year [2032] USD 1,420.27 million
CAGR (%) 9.03%

Contextualizing the critical clinical and technological imperatives that shape the design, adoption, and performance expectations for multi-use drainage catheters

Multi-use drainage catheters occupy a central role in contemporary interventional practice across several clinical specialties, enabling continuous drainage, targeted therapies, and diagnostic sampling within diverse care settings. Advances in materials science, device design, and procedural techniques have extended the clinical utility of these devices while elevating expectations around safety, longevity, and patient comfort. In parallel, shifting care models that emphasize outpatient procedures and ambulatory management have broadened the contexts in which drainage catheters are deployed, influencing clinician preferences and procurement priorities.

Clinical stakeholders increasingly demand devices that balance ease of insertion and maintenance with infection control and biocompatibility. This has driven incremental innovation in device geometry, surface treatments, and lumen architecture to optimize flow dynamics and reduce occlusion risk. At the same time, regulatory scrutiny and reimbursement frameworks are shaping product development decisions, requiring manufacturers to demonstrate clear clinical benefit and cost-consequence advantages. As a result, research and development leaders are prioritizing cross-disciplinary collaboration among clinicians, material scientists, and engineers to align next-generation designs with procedural workflows and patient-centered outcomes.

Taken together, these factors are creating a dynamic environment in which technological capability, clinical evidence, and operational practicality must converge. Translating these convergent forces into commercially viable products requires an integrated approach that anticipates clinician needs, addresses supply chain resilience, and accommodates evolving regulatory expectations.

Identifying transformative clinical, material, and commercial shifts that are redefining product development and procurement pathways for drainage catheter solutions

The landscape for multi-use drainage catheters is being reshaped by several transformative shifts that collectively influence clinical practice, procurement behavior, and product development priorities. First, material innovations focusing on polyurethane, silicone, and Teflon variants are enabling improved biocompatibility and reduced encrustation, which in turn are prompting clinicians to reassess device selection based on long-term performance attributes. Concurrently, advances in lumen architecture, including single lumen, double lumen, and triple lumen configurations, are expanding device functionality to meet complex drainage and therapeutic needs within a single intervention.

Second, the migration of procedures toward ambulatory surgery centers and outpatient specialty centers is changing demand patterns and driving an emphasis on devices that facilitate rapid turnover, simplified maintenance, and minimized infection risk. In addition, digital health and remote monitoring solutions are beginning to interface with drainage systems to provide early warning for occlusion or infection, setting the stage for smarter device ecosystems. Third, procurement discipline and supplier consolidation among hospital systems are increasing expectations around supply chain transparency, total cost of ownership, and device training support.

Together, these shifts are encouraging manufacturers to pursue modular product lines, invest in clinical evidence generation across cardiology, gastroenterology, nephrology, and urology applications, and develop commercial models that align with evolving care delivery and reimbursement frameworks.

Assessing the practical implications of 2025 United States tariff changes on device sourcing, supplier strategies, and supply chain resilience for drainage catheter manufacturers

Recent tariff developments in the United States during 2025 have introduced new considerations for sourcing strategies, supplier selection, and cost management across the medical device supply chain. Tariff adjustments are altering the comparative economics of manufacturing locations and have prompted firms to reassess the balance between offshore production and regional manufacturing options. As a result, procurement teams and supply chain leaders are placing greater emphasis on supply base diversification and qualification of alternate suppliers to mitigate exposure to tariff-related cost volatility.

In addition, regulatory compliance and customs classification nuances are drawing increased attention, particularly for components such as specialized polymers, coatings, and connector assemblies used in multi-use drainage catheters. These inputs often cross multiple tariff lines, and changes in duty rates can influence decisions around component sourcing, in-house manufacturing versus outsourcing, and inventory strategies. Consequently, manufacturers are evaluating nearshoring or dual-sourcing approaches to reduce lead-time risk and to retain flexibility in response to policy shifts.

Moreover, tariff-driven cost pressures are accelerating conversations about value engineering and design optimization to maintain competitive pricing without compromising clinical performance. This includes exploring material substitutions, streamlined bill-of-materials, and process improvements in assembly. Collectively, tariff dynamics in 2025 are catalyzing more strategic supply chain design, putting a premium on contractual resilience and scenario planning that aligns procurement, regulatory, and commercial teams.

Segment-driven strategic imperatives that link device configurations, clinical applications, end-user dynamics, materials, sizing and channel choices to commercialization success

A segmentation-focused lens reveals differentiated opportunities and operational priorities across product types, clinical uses, end-user settings, materials, device sizes, and sales channels that shape commercial and development strategies. Product type considerations distinguish between double lumen, single lumen, and triple lumen configurations, each offering different clinical trade-offs in terms of functionality, insertion complexity, and maintenance needs. Application variability across cardiology, gastroenterology, nephrology, and urology introduces distinct performance requirements, sterilization practices, and clinician training imperatives, which should inform targeted clinical evidence generation and labeling strategies.

End user dynamics span ambulatory surgery centers, clinics, hospitals, and specialty centers, with each setting placing unique demands on device robustness, supply chain cadence, and post-procedural support. Material selection-whether polyurethane, silicone, or Teflon-affects device flexibility, encrustation resistance, and compatibility with adjunct therapies, and should be aligned to the clinical context and expected dwell times. Size differentiation across 11-14 Fr, 5-7 Fr, 8-10 Fr, and >14 Fr categories impacts insertion technique, drainage capacity, and patient comfort, necessitating clear sizing guidance and clinician education programs.

Finally, sales channel strategies that encompass direct sales, distributor networks, and online sales platforms each offer distinct advantages for market access, service-level agreements, and customer relationship management. Understanding how these segmentation dimensions interact will enable companies to prioritize product portfolios, tailor messaging to clinical stakeholders, and optimize distribution models for differential adoption across care settings.

Highlighting how distinct regional regulatory, clinical and procurement characteristics across the Americas, Europe Middle East & Africa and Asia-Pacific shape product strategy

Regional dynamics exert a strong influence on regulatory requirements, reimbursement realities, and clinical practice norms, creating differentiated priorities for product development and commercial execution. In the Americas, there is concentrated emphasis on compliance with centralized regulatory processes and the need to align device claims with payer criteria, an environment that frequently drives rigorous clinical evidence generation and structured hospital procurement engagements. Conversely, Europe, Middle East & Africa presents a mosaic of regulatory regimes and procurement behaviors, which often necessitates localized regulatory strategies, adaptable labeling, and flexible distribution approaches to address varied national requirements and clinical traditions.

Asia-Pacific demonstrates rapid adoption of innovative procedural approaches and a growing capacity for regional manufacturing and component sourcing. This region's heterogeneity in clinical practice, regulatory maturity, and supplier ecosystems creates both opportunities for scale and complexities in market entry. In each region, differences in hospital infrastructure, prevalence of ambulatory care models, and clinician training pathways will influence the prioritization of device features such as ease of maintenance, infection control enhancements, and clinician onboarding materials.

Therefore, a geographically nuanced approach is essential. Manufacturers must tailor regulatory dossiers, engagement plans with key clinical opinion leaders, and distribution strategies to account for regional variations in procurement cycles, reimbursement mechanisms, and procedural norms.

Corporate differentiation insights that outline how innovation focus, manufacturing excellence, clinical partnerships and commercial models determine competitive advantage

Company-level dynamics in the multi-use drainage catheter arena reflect a balance between innovation leadership, manufacturing capabilities, and commercial reach. Leading firms are differentiating through investments in advanced materials and coating technologies, regulatory expertise to secure broad labeling, and partnerships with healthcare systems to generate real-world evidence. Strategic collaborations with academic centers and specialty clinicians are enhancing product credibility and accelerating clinical adoption by demonstrating procedural efficiencies and patient-centered outcomes.

Operational excellence in manufacturing and supply chain management is a differentiator for companies seeking to maintain reliability in the face of tariff and logistics headwinds. Firms investing in validated supplier networks, quality management systems, and scalable assembly capacity are better positioned to meet stringent hospital procurement requirements. Additionally, companies that integrate strong customer support-through training programs, clinical education, and post-sale technical services-are more effective at sustaining long-term adoption and reducing device-related complications.

Finally, competitive positioning is affected by commercial model choices; those combining direct sales forces for complex accounts with distributor partnerships and selective online channels can optimize reach across hospitals, specialty centers, clinics, and ambulatory surgery centers. A focused approach to clinical evidence generation, coupled with robust supply chain resilience and tailored commercial models, tends to distinguish companies that achieve durable clinical and commercial traction.

Practical and prioritized strategic actions that align product design, supply resilience, clinical evidence and commercial channels to drive adoption and reduce risk

Industry leaders can adopt a set of prioritized, actionable measures to navigate current clinical, regulatory, and commercial challenges while accelerating adoption and sustaining growth. First, aligning product development with clinician workflow requirements and materials performance objectives will ensure that design changes translate into measurable improvements in usability and patient outcomes. This requires iterative clinician input during development and targeted post-market surveillance to validate real-world performance.

Second, strengthening supply chain resilience through diversified sourcing, dual-sourcing of critical components, and selective nearshoring options will reduce exposure to tariff-driven cost shifts and logistical disruption. Third, investing in tailored clinical evidence programs across cardiology, gastroenterology, nephrology, and urology will strengthen value propositions for payers and procurement teams, particularly when those studies demonstrate reductions in procedural complications or downstream resource use. Fourth, optimize commercial coverage by blending direct sales for complex institutional accounts with distributor and digital channels to reach clinics and ambulatory centers efficiently.

Finally, prioritize training and service bundles that reduce device-related complications and improve clinician satisfaction. By coordinating R&D, supply chain, clinical affairs, and commercial teams around these actions, organizations can create repeatable playbooks for product introduction and scale in diverse care settings.

Transparent description of the multi-source research methodology, evidence triangulation, and validation steps used to derive actionable insights for stakeholders

This study synthesizes primary interviews with clinicians, procurement professionals, and industry executives, augmented by secondary analysis of regulatory guidance, clinical literature, and supply chain data to ensure robust triangulation of findings. Primary research encompassed structured consultations with interventional specialists across cardiology, gastroenterology, nephrology, and urology, as well as procurement and supply chain leaders from hospitals, ambulatory surgery centers, clinics, and specialty centers. These conversations were employed to surface real-world device performance priorities, purchasing rationales, and service expectations.

Secondary research involved a systematic review of peer-reviewed clinical studies, regulatory documentation, and materials science literature relating to polyurethane, silicone, and Teflon device performance and biocompatibility. In addition, supply chain and tariff analyses were informed by customs classification documentation and public policy releases to contextualize procurement implications. Findings from primary and secondary sources were cross-validated through iterative analyst review and expert panel consultation to mitigate bias and to confirm practical relevance.

Where gaps in published evidence existed, targeted case reviews and device-level performance summaries were used to inform practical implications. The methodology emphasizes transparency, reproducibility, and a clear line of sight between source evidence and strategic recommendations.

Synthesis of strategic implications that connect device innovation, clinical practice evolution, supply resilience and commercialization for decisive stakeholder action

In synthesis, the confluence of material advancement, procedural migration to outpatient settings, and evolving supply chain pressures is reshaping priorities for manufacturers and clinical stakeholders in the drainage catheter domain. Device designers must balance flexibility, resistance to encrustation, and lumen design to meet diverse clinical needs while operational leaders must anticipate procurement dynamics driven by tariff shifts and regional regulatory complexity. Commercial success will therefore depend on the ability to align clinical evidence, supply resilience, and tailored distribution approaches to the specific demands of hospitals, ambulatory centers, clinics, and specialty units.

Clinicians and procurement professionals stand to benefit when manufacturers produce clear comparative evidence on device performance across the relevant sizes and lumen configurations and provide robust training and service support to reduce complications and optimize outcomes. Manufacturers that integrate regional regulatory strategies and flexible production footprints will be better positioned to respond to shifting trade policy and to local clinical preferences. Ultimately, the effective translation of technical innovation into clinical and commercial value requires coordinated cross-functional execution, ongoing engagement with clinical users, and disciplined scenario planning to navigate policy and supply uncertainties.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Multi-Use Drainage Catheters Market, by Product Type

  • 8.1. Double Lumen
  • 8.2. Single Lumen
  • 8.3. Triple Lumen

9. Medical Multi-Use Drainage Catheters Market, by Material

  • 9.1. Polyurethane
  • 9.2. Silicone
  • 9.3. Teflon

10. Medical Multi-Use Drainage Catheters Market, by Size

  • 10.1. 11-14 Fr
  • 10.2. 5-7 Fr
  • 10.3. 8-10 Fr
  • 10.4. >14 Fr

11. Medical Multi-Use Drainage Catheters Market, by Application

  • 11.1. Cardiology
  • 11.2. Gastroenterology
  • 11.3. Nephrology
  • 11.4. Urology

12. Medical Multi-Use Drainage Catheters Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Clinics
  • 12.3. Hospitals
  • 12.4. Specialty Centers

13. Medical Multi-Use Drainage Catheters Market, by Sales Channel

  • 13.1. Direct Sales
  • 13.2. Distributor Sales
  • 13.3. Online Sales

14. Medical Multi-Use Drainage Catheters Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Medical Multi-Use Drainage Catheters Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Medical Multi-Use Drainage Catheters Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Medical Multi-Use Drainage Catheters Market

18. China Medical Multi-Use Drainage Catheters Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AngioDynamics, Inc.
  • 19.6. B. Braun Melsungen AG
  • 19.7. Becton, Dickinson and Company
  • 19.8. Boston Scientific Corporation
  • 19.9. Convatec Group Plc
  • 19.10. Cook Medical LLC
  • 19.11. Johnson & Johnson
  • 19.12. Medtronic plc
  • 19.13. Merit Medical Systems, Inc.
  • 19.14. Teleflex Incorporated
  • 19.15. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY TEFLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY TEFLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY TEFLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 11-14 FR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 11-14 FR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 11-14 FR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 5-7 FR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 5-7 FR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 5-7 FR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 8-10 FR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 8-10 FR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 8-10 FR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY >14 FR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY >14 FR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY >14 FR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY NEPHROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY NEPHROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 160. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)